Bulgaria vs Guinea-Bissau: Access to anti-retroviral drugs, male
Bulgaria
63.0%
in 2024
Guinea-Bissau
62.0%
in 2024
Bulgaria rank
92nd
Guinea-Bissau rank
94th
Access to anti-retroviral drugs, male over time
- Bulgaria
- Guinea-Bissau
How they compare
Bulgaria currently reports 63.0% against 62.0% in Guinea-Bissau, a difference of 1.0%.
Across all 25 years both countries report, Bulgaria has been ahead every year.
Bulgaria ranks 92nd and Guinea-Bissau ranks 94th of 141 countries.
Bulgaria has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Bulgaria | Guinea-Bissau | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 8.6% | 2.0% | 6.6% | Bulgaria |
| 2010s | 33.2% | 19.4% | 13.8% | Bulgaria |
| 2020s | 60.4% | 48.0% | 12.4% | Bulgaria |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Bulgaria or Guinea-Bissau?
- Bulgaria, at 63.0% against 62.0% in Guinea-Bissau as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Bulgaria and Guinea-Bissau?
- 1.0%, with Bulgaria ahead.
- How many years of comparable data are there for Bulgaria and Guinea-Bissau?
- 25 years are reported by both, from 2000 to 2024.
- How do Bulgaria and Guinea-Bissau rank globally for access to anti-retroviral drugs, male?
- Bulgaria ranks 92nd and Guinea-Bissau ranks 94th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.